Colesevelam Hydrochloride
Showing 1 - 25 of 1,811
Bile Acid Malabsorption, Chronic Diarrhea Trial in Denmark (Colesevelam Hydrochloride, Placebo oral capsule)
Completed
- Bile Acid Malabsorption
- Chronic Diarrhea
- Colesevelam Hydrochloride
- Placebo oral capsule
-
Aalborg, Denmark
- +3 more
Mar 2, 2022
Fecal Incontinence, Bile Acid Malabsorption Trial in Rochester (Colesevelam, Clonidine, Placebo)
Completed
- Fecal Incontinence
- Bile Acid Malabsorption
- Colesevelam
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 30, 2022
Early-stage Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive Trial (Neratinib, Loperamide, Colesevelam)
Not yet recruiting
- Early-stage Breast Cancer
- +2 more
- Neratinib
- +2 more
- (no location specified)
Aug 5, 2022
Type 2 Diabetes Trial in United States (High-dose colesevelam, Low-dose colesevelam)
Completed
- Type 2 Diabetes Mellitus
- High-dose colesevelam
- Low-dose colesevelam
-
Tucson, Arizona
- +23 more
Apr 16, 2021
Sitosterolemia Trial in Winnipeg (Colesevelam, Fish Oil, Combination of fish oil and colesevelam)
Unknown status
- Sitosterolemia
- Colesevelam
- +2 more
-
Winnipeg, Manitoba, CanadaRichardson Center for Functional Foods and Nutraceuticals
Nov 6, 2020
Prospective German Very High Cardiovascular Risk Patients
Recruiting
- Dyslipoproteinemias
- PCSK9 Inhibitor [EPC]
- Standard lipid lowering therapy
-
Dresden, GermanyMedizinische Klinik und Poliklinik III
Mar 18, 2022
Coronary Artery Disease, Carotid Artery Diseases, Atherosclerosis Trial in United States (Atorvastatin, Niacin, Colesevelam)
Completed
- Coronary Artery Disease
- +2 more
- Atorvastatin
- +4 more
-
Los Angeles, California
- +3 more
May 16, 2022
Nonalcoholic Steatohepatitis Trial in La Jolla, San Diego (Colesevelam Hcl)
Completed
- Nonalcoholic Steatohepatitis
- Colesevelam Hcl
-
La Jolla, California
- +1 more
Jul 1, 2020
Severe Obesity Trial in Hvidovre (Colesevelam, Chenodeoxycholic Acid, Water)
Completed
- Severe Obesity
- Colesevelam
- +2 more
-
Hvidovre, DenmarkHvidovre University Hospital
Nov 25, 2020
Severe Obesity Trial in Hvidovre (Chenodeoxycholic Acid, Colesevelam)
Completed
- Severe Obesity
- Chenodeoxycholic Acid
- Colesevelam
-
Hvidovre, DK, DenmarkHvidovre University Hospital
Nov 25, 2020
Colesevelam, Lipids And Sugars, South Asian Canadian Trial
Completed
- Dyslipidemia
-
Brampton, Ontario, CanadaDr. Milan Gupta,MD
Jan 22, 2020
Chronic Diarrhea, Irritable Bowel Syndrome With Diarrhea, Bile Acid Malabsorption Trial in Rochester (Colesevelam, Placebo)
Completed
- Chronic Diarrhea
- +2 more
- Colesevelam
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 14, 2020
Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)
Recruiting
- Diabetic Peripheral Neuropathic Pain
- HSK16149 20mg BID
-
Luoyang, Henan, ChinaThe First Affiliated Hospital of Henan University of Science and
Nov 2, 2023
Laparoscopy, Anesthesia, Intravenous Trial in China (BT-KTM-I, Ketanest®S)
Not yet recruiting
- Laparoscopy
- Anesthesia, Intravenous
-
Guangzhou, Guangdong, China
- +11 more
Oct 15, 2023
Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)
Active, not recruiting
- Adult Solid Neoplasm
- Erlotinib Hydrochloride
- Irinotecan Hydrochloride
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 12, 2023
Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin
Not yet recruiting
- Pain
- Insomnia
- Compound ibuprofen polyrelease tablets
- reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Feb 6, 2023
Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)
Not yet recruiting
- Breast Cancer
- Mitoxantrone hydrochloride liposome
- Capecitabine
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023
Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Propranolol
- Propranolol hydrochloride
- +2 more
- (no location specified)
Jul 31, 2023
Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)
Not yet recruiting
- Platinum-resistant Ovarian Cancer
- Oral Topotecan Combined With Anlotinib
-
Shanghai, ChinaXinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023
Type 2 Diabetes Trial in Canada (Colesevelam, Ezetimibe)
Completed
- Type 2 Diabetes Mellitus
-
Calgary, Alberta, Canada
- +8 more
Nov 22, 2019
Associated With Cardiomyopathy and Heart Failure After Cancer
Recruiting
- Hodgkin Lymphoma in Remission
- +6 more
- Assessment of Therapy Complications
- +3 more
-
Birmingham, Alabama
- +78 more
Jan 11, 2023
Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)
Not yet recruiting
- Myelofibrosis
- Jaktinib Hydrochloride Tablets
-
Changsha, Hunan, ChinaThe Third Hospital of Changsha
Nov 9, 2023
Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in
Active, not recruiting
- Pancreatic Acinar Cell Carcinoma
- +8 more
- 3-Dimensional Conformal Radiation Therapy
- +8 more
-
Mobile, Alabama
- +697 more
Nov 16, 2022
Nausea and Vomiting Trial in Xi'an (Palonosetron HCl capsules)
Recruiting
- Nausea and Vomiting
- Palonosetron hydrochloride capsules
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital, the Air Force Medical University
Jan 18, 2023